Clinical Trials Browser

Phase 1/2 × INDUSTRY × rezivertinib × Clear all

NCT03386955 2022-05-16

BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung